176 related articles for article (PubMed ID: 19033487)
1. Comment: Clinical pharmaceutics and calcium ceftriaxone.
Puzovic M; Hardy G
Ann Pharmacother; 2008 Dec; 42(12):1914. PubMed ID: 19033487
[No Abstract] [Full Text] [Related]
2. Clinical pharmaceutics and calcium ceftriaxone.
Rapp RP; Kuhn R
Ann Pharmacother; 2007 Dec; 41(12):2072. PubMed ID: 17986514
[No Abstract] [Full Text] [Related]
3. Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation.
Iida S; Kawanishi T; Hayashi M
J Pharm Pharmacol; 2011 Jan; 63(1):65-72. PubMed ID: 21155817
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmaceutics and calcium-ceftriaxone.
Gin AS; Wheaton H; Dalton B
Ann Pharmacother; 2008 Mar; 42(3):450-1. PubMed ID: 18230702
[No Abstract] [Full Text] [Related]
5. Ceftriaxone crystallization and its potential role in kidney stone formation.
Chutipongtanate S; Thongboonkerd V
Biochem Biophys Res Commun; 2011 Mar; 406(3):396-402. PubMed ID: 21329669
[TBL] [Abstract][Full Text] [Related]
6. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events.
Bradley JS; Wassel RT; Lee L; Nambiar S
Pediatrics; 2009 Apr; 123(4):e609-13. PubMed ID: 19289450
[TBL] [Abstract][Full Text] [Related]
7. Perioperative antibacterial prophylaxis in bone surgery: sufficiently high tissue levels with ceftriaxone (rocephin) 24 hours after a single dose of 2 g.
Rudert W; Hennecke H; Adam D
J Chemother; 1989 Jul; 1(4 Suppl):1046-7. PubMed ID: 16312765
[No Abstract] [Full Text] [Related]
8. Ceftriaxone pharmacokinetic properties during continuous veno-veno haemofiltration using an in vitro adult, paediatric and neonatal model.
Harvey B; Johnson TN; Yeomanson D; Mulla H; Mayer AP
Perfusion; 2014 Jan; 29(1):32-8. PubMed ID: 23863489
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a potential clinical interaction between ceftriaxone and calcium.
Steadman E; Raisch DW; Bennett CL; Esterly JS; Becker T; Postelnick M; McKoy JM; Trifilio S; Yarnold PR; Scheetz MH
Antimicrob Agents Chemother; 2010 Apr; 54(4):1534-40. PubMed ID: 20086152
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of ceftriaxone, cefmetazole and moxalactam during abdominal surgery.
Shinagawa N
J Chemother; 1989 Jul; 1(4 Suppl):524-5. PubMed ID: 16312514
[No Abstract] [Full Text] [Related]
11. Biliary precipitation during ceftriaxone therapy: frequency and risk factors.
Soysal A; Eraşov K; Akpinar I; Bakir M
Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia.
Arnet I; Altermatt M; Roggo Y; Schnetzler G
J Chemother; 2015; 27(6):337-42. PubMed ID: 25144924
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of surgical infection by using delayed- and non-delayed action antibiotics].
Hell K
Antibiot Khimioter; 1992 Jul; 37(7):38-40. PubMed ID: 1456808
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics and dose individualization of ceftriaxone in a hepatically-impaired, critically-ill patient receiving continuous venovenous hemofiltration.
Meenks SD; Foudraine NA; Janssen PKC; le Noble JLML
Int J Clin Pharmacol Ther; 2018 Mar; 56(3):148-150. PubMed ID: 29336776
[No Abstract] [Full Text] [Related]
15. Rational drug therapy in children.
Bodhankar U
J Indian Med Assoc; 1996 Dec; 94(12):449-51. PubMed ID: 9141853
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics of ceftriaxione, a third-generation cephalosporin, in pediatric patients.
Fukumoto K; Aida S; Oishi T; Ueno K
Biol Pharm Bull; 2009 Jul; 32(7):1139-41. PubMed ID: 19571374
[TBL] [Abstract][Full Text] [Related]
17. CSF concentration of ceftriaxone following high-dose administration: pharmacological data from two French cohorts.
Le Turnier P; Grégoire M; Garot D; Guimard T; Duval X; Bernard L; Boutoille D; Dailly É; Navas D; Asseray N
J Antimicrob Chemother; 2019 Jun; 74(6):1753-1755. PubMed ID: 30793755
[No Abstract] [Full Text] [Related]
18. Clinical inquiries. Should you use antibiotics to treat acute otitis media in children?
Gamboa S; Park MK; Wanserski G; Lo V
J Fam Pract; 2009 Nov; 58(11):602-4. PubMed ID: 19891939
[No Abstract] [Full Text] [Related]
19. The Role of an Impurity in Ceftriaxone Sodium Preparation for Injection in Determining Compatibility with Calcium-Containing Solutions.
Tange M; Yoshida M; Nakai Y; Uchida T
Chem Pharm Bull (Tokyo); 2016; 64(3):207-14. PubMed ID: 26936047
[TBL] [Abstract][Full Text] [Related]
20. Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy.
Harvey WT; Martz D
Acta Neurol Scand; 2007 Feb; 115(2):129-31. PubMed ID: 17212618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
